[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2011 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- -49.04%
YoY- 66.37%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 1,520,981 1,153,195 781,763 385,328 1,378,348 1,002,232 667,895 72.83%
PBT 73,186 56,818 41,172 21,792 45,462 48,163 32,758 70.64%
Tax -20,401 -16,215 -11,528 -6,193 -15,152 -15,901 -8,931 73.18%
NP 52,785 40,603 29,644 15,599 30,310 32,262 23,827 69.69%
-
NP to SH 52,157 40,215 29,404 15,484 30,384 32,640 24,054 67.29%
-
Tax Rate 27.88% 28.54% 28.00% 28.42% 33.33% 33.01% 27.26% -
Total Cost 1,468,196 1,112,592 752,119 369,729 1,348,038 969,970 644,068 72.94%
-
Net Worth 514,273 464,307 451,381 437,661 421,524 424,715 417,306 14.90%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 35,304 - - - 10,698 50,281 50,290 -20.96%
Div Payout % 67.69% - - - 35.21% 154.05% 209.07% -
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 514,273 464,307 451,381 437,661 421,524 424,715 417,306 14.90%
NOSH 117,682 106,983 106,962 107,007 106,985 106,981 107,001 6.53%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 3.47% 3.52% 3.79% 4.05% 2.20% 3.22% 3.57% -
ROE 10.14% 8.66% 6.51% 3.54% 7.21% 7.69% 5.76% -
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 1,292.44 1,077.92 730.88 360.09 1,288.35 936.83 624.19 62.23%
EPS 44.32 37.59 27.49 14.47 28.40 30.51 22.48 57.03%
DPS 30.00 0.00 0.00 0.00 10.00 47.00 47.00 -25.80%
NAPS 4.37 4.34 4.22 4.09 3.94 3.97 3.90 7.85%
Adjusted Per Share Value based on latest NOSH - 107,007
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 105.53 80.01 54.24 26.74 95.64 69.54 46.34 72.83%
EPS 3.62 2.79 2.04 1.07 2.11 2.26 1.67 67.25%
DPS 2.45 0.00 0.00 0.00 0.74 3.49 3.49 -20.96%
NAPS 0.3568 0.3222 0.3132 0.3037 0.2925 0.2947 0.2895 14.90%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 5.36 5.90 5.90 5.73 5.31 4.98 4.98 -
P/RPS 0.41 0.55 0.81 1.59 0.41 0.53 0.80 -35.88%
P/EPS 12.09 15.70 21.46 39.60 18.70 16.32 22.15 -33.13%
EY 8.27 6.37 4.66 2.53 5.35 6.13 4.51 49.64%
DY 5.60 0.00 0.00 0.00 1.88 9.44 9.44 -29.33%
P/NAPS 1.23 1.36 1.40 1.40 1.35 1.25 1.28 -2.61%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 11/08/10 -
Price 5.90 5.90 5.90 5.05 5.35 4.92 4.95 -
P/RPS 0.46 0.55 0.81 1.40 0.42 0.53 0.79 -30.20%
P/EPS 13.31 15.70 21.46 34.90 18.84 16.13 22.02 -28.44%
EY 7.51 6.37 4.66 2.87 5.31 6.20 4.54 39.74%
DY 5.08 0.00 0.00 0.00 1.87 9.55 9.49 -33.99%
P/NAPS 1.35 1.36 1.40 1.23 1.36 1.24 1.27 4.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment